On Monday, 4D Molecular Therapeutics Inc (NASDAQ: FDMT) opened higher 7.08% from the last session, before settling in for the closing price of $5.93. Price fluctuations for FDMT have ranged from $5.22 to $36.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 151.75% annually for the last half of the decade. Company’s average yearly earnings per share was noted -13.00% at the time writing. With a float of $38.13 million, this company’s outstanding shares have now reached $52.00 million.
In an organization with 147 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -43747.06%, operating margin of -990447.06%, and the pretax margin is -844000.0%.
4D Molecular Therapeutics Inc (FDMT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 4D Molecular Therapeutics Inc is 17.53%, while institutional ownership is 98.98%. The most recent insider transaction that took place on Sep 16 ’24, was worth 8,165. In this transaction Chief Legal Officer of this company sold 500 shares at a rate of $16.33, taking the stock ownership to the 6,781 shares. Before that another transaction happened on Aug 19 ’24, when Company’s Chief Legal Officer sold 500 for $15.00, making the entire transaction worth $7,500. This insider now owns 6,781 shares in total.
4D Molecular Therapeutics Inc (FDMT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -13.00% per share during the next fiscal year.
4D Molecular Therapeutics Inc (NASDAQ: FDMT) Trading Performance Indicators
Check out the current performance indicators for 4D Molecular Therapeutics Inc (FDMT). In the past quarter, the stock posted a quick ratio of 17.33.
Technical Analysis of 4D Molecular Therapeutics Inc (FDMT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.04 million. That was better than the volume of 0.84 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.60%. Additionally, its Average True Range was 0.46.
During the past 100 days, 4D Molecular Therapeutics Inc’s (FDMT) raw stochastic average was set at 9.27%, which indicates a significant decrease from 72.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.23% in the past 14 days, which was higher than the 67.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.30, while its 200-day Moving Average is $16.83. However, in the short run, 4D Molecular Therapeutics Inc’s stock first resistance to watch stands at $6.71. Second resistance stands at $7.08. The third major resistance level sits at $7.50. If the price goes on to break the first support level at $5.92, it is likely to go to the next support level at $5.50. The third support level lies at $5.13 if the price breaches the second support level.
4D Molecular Therapeutics Inc (NASDAQ: FDMT) Key Stats
There are currently 46,228K shares outstanding in the company with a market cap of 293.55 million. Presently, the company’s annual sales total 20,720 K according to its annual income of -100,840 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -34,950 K.
